Heng Liu

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 6

Top Topics

Signaling Pathway

Immune Response

Top Venues

Cancer research communications

Cancer immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Simona Lombardi, Aaron R Goldman, Hsin-Yao Tang, Andrew V Kossenkov, Heng Liu, Wei Zhou, Meenhard Herylyn, Jianhuang Lin, Rugang Zhang
Targeting Fatty Acid Reprogramming Suppresses CARM1-expressing Ovarian Cancer. Cancer research communications 3 (6) (2023)
Simona Lombardi, Aaron R Goldman, Hsin-Yao Tang, Andrew V Kossenkov, Heng Liu, Wei Zhou, Meenhard Herylyn, Jianhuang Lin, Rugang Zhang
Targeting Fatty Acid Reprogramming Suppresses CARM1-expressing Ovarian Cancer. Cancer research communications 3 (6) (2023)
Simona Lombardi, Aaron R Goldman, Hsin-Yao Tang, Andrew V Kossenkov, Heng Liu, Wei Zhou, Meenhard Herylyn, Jianhuang Lin, Rugang Zhang
Targeting Fatty Acid Reprogramming Suppresses CARM1-expressing Ovarian Cancer. Cancer research communications 3 (6) (2023)
Simona Lombardi, Aaron R Goldman, Hsin-Yao Tang, Andrew V Kossenkov, Heng Liu, Wei Zhou, Meenhard Herylyn, Jianhuang Lin, Rugang Zhang
Targeting Fatty Acid Reprogramming Suppresses CARM1-expressing Ovarian Cancer. Cancer research communications 3 (6) (2023)
Simona Lombardi, Aaron R Goldman, Hsin-Yao Tang, Andrew V Kossenkov, Heng Liu, Wei Zhou, Meenhard Herylyn, Jianhuang Lin, Rugang Zhang
Targeting Fatty Acid Reprogramming Suppresses CARM1-expressing Ovarian Cancer. Cancer research communications 3 (6) (2023)
Heng Liu, Jianhuang Lin, Wei Zhou, Renyta Moses, Zhongping Dai, Andrew V Kossenkov, Ronny Drapkin, Benjamin G Bitler, Sergey Karakashev, Rugang Zhang
KDM5A Inhibits Antitumor Immune Responses Through Downregulation of the Antigen-Presentation Pathway in Ovarian Cancer. Cancer immunology research 10 (8) (2022)